Skip to main content

No Signs Of Settlements In The Ongoing Xarelto Litigation

No Signs Of Settlements In The Ongoing Xarelto Litigation

No Signs Of Settlements In The Ongoing Xarelto Litigation

Introduction

No signs of settlements in the ongoing Xarelto Litigation currently underway in the Eastern District of Louisiana, leads U. S. District Judge Eldon Fallon to order two separate waves of lawsuits, each comprising 600 cases totaling to 1,200 lawsuits to be prepared for trial. These additional cases will go through case-specific discovery. The first wave requires the plaintiffs and defendants to pick their 200 cases each until April 16, 2018, and the court will make its random selections on April 30. Similarly, for the second wave, August 16 is set for the plaintiffs and defendants to submit their pick of cases to undergo a discovery process and August 30 for the court to make its random selections.

Bayer and Johnson & Johnson's Janssen division are facing more than 18,000 cases nationwide wherein each allegation points that users and the medical community were not adequately warned about the risk of uncontrollable bleeding on Xarelto.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!